Sunitinib and Reversible Posterior Leukoencephalopathy Syndrome: the usual suspect but not always the culprit. A case report.
References
- Cancer Genome Atlas Research, N., et al.,
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma . N Engl J Med, 2016. 374(2): p. 135–45. - Shuch B., et al.,
Current treatment Landscape of Advanced Papillary Renal Cell Cancer. Journal of Clinical Oncology, Vol 35, No26, (Sept 10), 2017: pp 2981–2983 - Schmid, T.A. and M.E. Gore,
Sunitinib in the treatment of metastatic renal cell carcinoma . Ther Adv Urol, 2016. 8(6): p. 348–371. - Fukui, S., et al,
Reversible Posteior Leukoencephalopathy Syndrome Developing After restart of Sunitinib Therapy for Metastatic Renal Cell Carcinoma . Case Reports in Medicine, Vol 2016, Article ID 6852951 - Stenman, M., et al,
Metastatic papillary renal cell carcinoma in the era of targeted therapy - a retrospective study from three European academic centres . Acta Oncologica, 58:3,306–312, DOI: 10.1080/0284186X.2018.1537505 - Khan, K.H. et al,
Reversible posterior leukoencephalopathy syndrome following sunitinib therapy: a case report and review of the literature . Tumori, 2012. 98: e139–e142. - Hinduja, A.,
Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome . Front Neurol, 2020. 11: p. 71. - Gao, B., et al.,
Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years? J Neurol Neurosurg Psychiatry, 2018. 89(1): p. 14–20. - Kastrup, O., et al.,
Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns . J Neurol, 2012. 259(7): p. 1383–9. - Fugate, J.E. and A.A. Rabinstein,
Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions . Lancet Neurol, 2015. 14(9): p. 914–925.
Language: English
Page range: 14 - 18
Submitted on: Jul 17, 2024
Accepted on: Nov 13, 2024
Published on: Apr 15, 2025
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Related subjects:
© 2025 Ourania Katopodis, Maria Lerikou, Georgios Karagiorgis, Spyridon Arvanitakis, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.